Lloyd’s of London:企業の戦略・SWOT・財務情報

◆英語タイトル:Lloyd's of London - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1169
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Lloyd’s of London – Strategy, SWOT and Corporate Finance Report
Summary

Lloyd’s of London – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Lloyd’s of London (Lloyd’s) is an insurance market, which offers specialist insurance services to businesses. It focuses on conducting insurance business through members of Lloyd’s and the protection of their interests. The business is written at Lloyd’s through brokers, who facilitate the risk-transfer process between underwriters and clients (policyholders). It offers insurance products for aviation, accident and health, medical expenses, term life, professional indemnity, cargo, casualty, general liability, power generation and agriculture and hail. It serves start-ups, small and medium-sized enterprises multinational corporations and national governments. Lloyd’s operates in the UK, the Americas, Europe, Central Asia and Asia Pacific. It is headquartered in London, the UK.

The company reported gross written premiums of EUR33,591 million in FY2017, an increase of 12.5% over FY2016. Its net premium written was EUR 24,869 million in FY2017, an increase of 7.8% over FY2016.

Scope

- Detailed information on Lloyd’s of London required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Lloyd’s of London in the form of a SWOT analysis
- An in-depth view of the business model of Lloyd’s of London including a breakdown and examination of key business segments
- Intelligence on Lloyd’s of London’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Lloyd’s of London, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Lloyd’s of London and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Lloyd’s of London as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Lloyd’s of London’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Lloyd’s of London: Company Overview 6
Lloyd’s of London: Overview and Key Facts 6
Lloyd’s of London: Overview 6
Lloyd’s of London: Key Facts 6
Lloyd’s of London: Key Employees 7
Lloyd’s of London: Key Employee Biographies 9
Lloyd’s of London: Major Products and Services 12
Lloyd’s of London: Company History 13
Lloyd’s of London: Management Statement 17
Lloyd’s of London: Locations and Subsidiaries 19
Lloyd’s of London: Key Competitors 20
Lloyd’s of London: Company Analysis 21
Lloyd’s of London: Business Description 21
Lloyd’s of London: SWOT Analysis 22
Lloyd’s of London: SWOT Overview 22
Lloyd’s of London: Strengths 22
Lloyd’s of London: Weaknesses 23
Lloyd’s of London: Opportunities 23
Lloyd’s of London: Threats 24
Lloyd’s of London: Recent Developments 25
Lloyd’s of London: News and Events Summary 25
Lloyd’s of London: Business Expansion 28
Lloyd’s of London: Corporate Governance 29
Lloyd’s of London: Financial Deals 29
Lloyd’s of London: Regulatory and Legal Events 30
Lloyd’s of London: Strategy and Operations 30
Appendix 32
Contact Us 32
Methodology 32
About MarketLine 33

List of Tables
Table 1: Lloyd's of London: Key Facts
Table 2: Lloyd's of London: Key Employees
Table 3: Lloyd's of London: Locations and Subsidiaries
Table 4: Lloyd's of London: Key Competitors
Table 5: Lloyd's of London: News and Events Summary
Table 6: Lloyd's of London: Business Expansion
Table 7: Lloyd's of London: Corporate Governance
Table 8: Lloyd's of London: Financial Deals
Table 9: Lloyd's of London: Regulatory and Legal Events
Table 10: Lloyd's of London: Strategy and Operations



★海外企業調査レポート[Lloyd’s of London:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Commercial International Bank (Egypt) S.A.E.:戦略・SWOT・企業財務分析
    Commercial International Bank (Egypt) S.A.E. - Strategy, SWOT and Corporate Finance Report Summary Commercial International Bank (Egypt) S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • Mersana Therapeutics Inc (MRSN)-製薬・医療分野:企業M&A・提携分析
    Summary Mersana Therapeutics Inc (Mersana) formerly Nanopharma Corp, is a biotechnology company that develops immunoconjugate therapies to improve patients’ lives. The company offers pipeline product XMT-1522, for HER-2 targeted therapies based on its Dolaflexin platform. It utilizes its Fleximer an …
  • Sykes Enterprises, Incorporated:企業の戦略・SWOT・財務分析
    Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Innsuites Hospitality Trust:企業の戦略・SWOT・財務分析
    Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report Summary Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nobel Biocare Services AG:企業の戦略的SWOT分析
    Nobel Biocare Services AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Zosano Pharma Corp (ZSAN):企業の財務・戦略的SWOT分析
    Summary Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc, is a clinical stage biopharmaceutical company that develops proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its drug formulations through the skin for the treatment o …
  • Aker BioMarine AS:企業の戦略・SWOT・財務分析
    Aker BioMarine AS - Strategy, SWOT and Corporate Finance Report Summary Aker BioMarine AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Thirau Inc.:企業の戦略的SWOT分析
    Thirau Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Juntendo University:製薬・医療:M&Aディール及び事業提携情報
    Summary Juntendo University (Juntendo) is a healthcare service provider that offers medical education and research programs and services. The university offers services such as medical education, practices and healthcare services including nursing, consultation, emergency room services, and others. …
  • MedImmune Ltd-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune Ltd (MedImmune), formerly Cambridge Antibody Technology Ltd, is a subsidiary of AstraZeneca Plc, is a research and development company that develops and commercializes small molecule and biologic prescription medicines for the prevention of respiratory tract disease caused by respi …
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • TWC Enterprises Limited:企業の戦略・SWOT・財務情報
    TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary TWC Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Samyang Biopharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Samyang Biopharmaceuticals Corp (Samyang Biopharm) researches and develops technology platforms for drug delivery. Its product portfolio comprises transdermal patches, injections, ORC hemostat and others. The company spans its expertise in the development and distribution of biodegradable, s …
  • GWA Group Ltd (GWA):企業の財務・戦略的SWOT分析
    GWA Group Ltd (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • University of Birmingham-医療機器分野:企業M&A・提携分析
    Summary University of Birmingham is an academic research university that offers educational services. The university provides undergraduate, postgraduate, postgraduate research, and distance learning programs. It offers educational courses in various fields including accounting, astronomy, computer …
  • Fluidic Analytics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Fluidic Analytics Ltd (Fluidic Analytics) is a biotechnology company that offers diagnostic tools to sequence and characterize proteins in laboratory, medical and consumer applications. The company offers Flow Mk-1 and Flow Mk-2 products. Flow Mk-1 is a lab instrument, which comprises dispos …
  • SQI Diagnostics Inc (SQD):企業の製品パイプライン分析2018
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that offers in vitro diagnostic and pharmaceutical research products. The company’s products comprise sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. …
  • Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Prolung Inc (LUNG):医療機器:M&Aディール及び事業提携情報
    Summary Prolung Inc(Prolung) formerly known as Fresh Medical Laboratories Inc, is a medical device company that offers diagnostic services. The company offers electro pulmonary nodule scanner system used for the non invasive early diagnostics of different types of diseases. Its EPN system consists o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆